Light Every Sight
Intalight was founded by a group of scientists and industry veterans of Silicon Valley in 2014 with a core mission to develop the most advanced ophthalmic technologies. In 2015, the company’s base of operations moved to mainland China, and there are now three sites in Silicon Valley, Shanghai, and Luoyang.
In 2019, Intalight released the first Swept-Source Optical Coherence Tomography (OCT) device that combines Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities, abbreviated as DREAM OCT™.
The powerful imaging device has become an indispensable tool for many ophthalmologists in not only their daily clinical use but also their exploration of the research frontiers. To date, over 100 papers have been published in peer-reviewed journals based on the findings using DREAM OCT™ devices.
Intalight will continue the innovation and push the limit of technologies. The product portfolios are extending from ophthalmic diagnostic devices to operational instruments. In doing so, Intalight aims to empower ophthalmologists and benefit the patients worldwide.
Light Every Sight
Intalight was founded by a group of scientists and industry veterans of Silicon Valley in 2014 with a core mission to develop the most advanced ophthalmic technologies. In 2015, the company’s base of operations moved to mainland China, and there are now three sites in Silicon Valley, Shanghai, and Luoyang.
In 2019, Intalight released the first Swept-Source Optical Coherence Tomography (OCT) device that combines Deep imaging depth, Rapid sweeping speed, Extensive scan range, Accurate lesion detection and Multimodal imaging capabilities, abbreviated as DREAM OCT™.
The powerful imaging device has become an indispensable tool for many ophthalmologists in not only their daily clinical use but also their exploration of the research frontiers. To date, over 100 papers have been published in peer-reviewed journals based on the findings using DREAM OCT™ devices.
Intalight will continue the innovation and push the limit of technologies. The product portfolios are extending from ophthalmic diagnostic devices to operational instruments. In doing so, Intalight aims to empower ophthalmologists and benefit the patients worldwide.
News
Intalight™ Positions Itself for Further Expansion in OCT Imaging in the US with a Novel Ophthalmic Platform and Executive Leadership
Cutting-edge Swept Source is the next generation of OCT MILPITAS, Calif. / 15 Nov 2022 SVision Imaging, a company that develops advanced ophthalmic technologies, today announced that it will be expanding its position as a leader in Optical Coherence Tomography (OCT) under the new name Intalight™. The rebranding [...]
News
Intalight™ Positions Itself for Further Expansion in OCT Imaging in the US with a Novel Ophthalmic Platform and Executive Leadership
Cutting-edge Swept Source is the next generation of OCT [...]
Contact
Silicon Valley Office
Shanghai Office
Luoyang Office
Contact
Silicon Valley Office
Shanghai Office